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Background: Patients with non-ST-segment elevation acute coronary syndrome (NSTE-ACS) have varying degrees
of salvageable myocardium at risk of irreversible injury. We hypothesized that a novel model of NSTE-ACS produces
acute myocardial injury, measured by increased T2 cardiovascular magnetic resonance (CMR), without significant
necrosis by late gadolinium enhancement (LGE).
Methods: In a canine model, partial coronary stenosis was created and electrodes placed on the epicardium.
Myocardial T2, an indicator of at-risk myocardium, was measured pre- and post-tachycardic pacing.
Results: Serum troponin-I (TnI) was not detectable in unoperated sham animals but averaged 1.97 ± 0.72 ng/mL
in model animals. Coronary stenosis and pacing produced significantly higher T2 in the affected vs. the remote
myocardium (53.2 ± 4.9 vs. 43.6 ± 2.8 ms, p < 0.01) with no evident injury by LGE. Microscopy revealed no significant
irreversible cellular injury. Relative respiration rate (RRR) of affected vs. remote myocardial tissue was significantly
lower in model vs. sham animals (0.72 ± 0.07 vs. 1.04 ± 0.07, p < 0.001). Lower RRR corresponded to higher final
TnI levels (R2 = 0.83, p = 0.004) and changes in CaMKIID and mitochondrial gene expression.
Conclusions: A large animal NSTE-ACS model with mild TnI elevation and without ST elevation, similar to the
human syndrome, demonstrates signs of acute myocardial injury by T2-CMR without significant irreversible damage.
Reduced tissue respiration and associated adaptations of critical metabolic pathways correspond to increased
myocardial injury by serum biomarkers in this model. T2-CMR as a biomarker of at-risk but salvageable myocardium
warrants further consideration in preclinical and clinical studies of NSTE-ACS.
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MitochondriaBackground
Non ST-segment elevation acute coronary syndrome
(NSTE-ACS) – a subset of acute coronary syndrome (ACS)
that includes non ST-segment elevation myocardial
infarction (NSTEMI) and unstable angina (UA) – is
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reproduction in any medium, provided the orpresentations each year in the United States alone [1,2].
While patients with ST-elevation myocardial infarction
(STEMI) have well defined evaluation and management
pathways, NSTE-ACS patients receive heterogeneous
care yet suffer similar if not greater morbidity and mortality
[3]. Paradoxically, there is worse adherence to guideline-
based management in higher risk vs. lower risk NSTE-ACS
patients [4]. At least some of the heterogeneity in initial
management likely stems from uncertainty regarding which
patients harbor at-risk but not yet irreversibly injured myo-
cardium that might benefit from accelerated invasive care.Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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indicate that damage has occurred, they cannot identify
myocardium that is at-risk but still salvageable. Cardio-
vascular magnetic resonance (CMR) with myocardial
T2 imaging has shown value as a noninvasive imaging
biomarker of at-risk myocardium, delineating myocar-
dium at-risk in both a large animal model of STEMI [5]
as well as in patients with STEMI [6]. Our group has
previously shown that CMR with T2 imaging may identify
at-risk but salvageable myocardium in patients with
NSTE-ACS [7], prompting us to seek further mechanistic
understanding for the basis of T2 increase in this
syndrome. In the present study, we tested the hypotheses
that i) T2 elevation without late gadolinium enhancement
(LGE) is present in a large animal model of NSTE-ACS
and ii) this finding represents acutely injured myocardium
that remains salvageable by ex vivo tissue analyses, despite
being at risk for subsequent irreversible damage, as
reflected by the induction of cardioprotective metabolic




An overview of the study protocol is shown in Figure 1.
All the animal procedures were approved by The Ohio
State University Institutional Animal Care and Use Com-
mittee and conformed to the Guide for the Care and Use
of Laboratory Animals published by the US National
Institutes of Health. Thirteen heartworm-free, random-
source, mixed-breed dogs (aged 1-3 years, weight 11.4-
15.9 kg) were anesthetized using ketamine (5-8 mg/kg, IM)
and inhaled isoflurane (1-2% in 95% O2) and remained
anesthetized throughout all experimental procedures. In 2
randomized dogs, no surgical operations were performed
(unoperated shams). ECG was monitored via surface
electrodes. After left thoracotomy in the remaining 11
dogs, a catheter was placed in the left atrial appendageFigure 1 Experiment procedure timeline. The diagram provides an over
animals underwent neither stenosis creation nor pacing, and 2 control animfor microsphere injection. In a random selection of 4
dogs, no further operations were performed prior to
closing of the chest wall (shams). In the 7 model dogs,
an 18-gauge needle was laid flat on the left circumflex
coronary artery (LCx) then removed once a suture was
secured around the artery and needle, leaving a lumen
constricted to the nominal outer diameter of the needle
(~1.27 mm). Copper pacing wires were then threaded
through the epicardium of the right ventricle and
connected to an external electrical stimulator for later
myocardial pacing. Standard chest wall closing procedures
and post-operative anesthesia and analgesia protocols
were then followed [10].
Serum isolated from peripheral blood drawn at 3 time
points (0-baseline prior to surgery, 1-post-stenosis and
post-pacing in model dogs or at the end of CMR examin-
ation in sham dogs, and 2-just before euthanasia) was ex-
amined for troponin I (TnI) content using a high-sensitivity
assay according to the manufacturer’s recommendations
(TnI-Ultra assay and ADVIA Centaur XP immunoanalyzer,
Siemens Healthcare Diagnostics; Malvern, PA).
Based on the anatomical perfusion territory of the LCx
and preliminary results from pilot studies, the lateral LV
myocardium at the level of the posterior papillary muscle
was denoted as the affected region while a section of the
anterior LV wall near the anterior papillary muscle was
designated as the remote region. At the conclusion of each
imaging experiment, the animal was euthanized and the
heart immediately harvested. Myocardium from affected
and remote regions was excised using the papillary
muscles as anatomical landmarks. Tissue samples from
each myocardial region were obtained for immediate
tissue respiration, wet-to-dry weight and tissue necrosis
analyses on fresh tissue. Additional samples were ac-
quired and either fixed or frozen (-80°C) for later light
and electron microscopy or gene expression analyses,
respectively, as discussed below and in the provided
online supplement (see Additional file 1).view of experimental procedures for the NSTE-ACS model. Sham
als had no thoracotomy.
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CMR was initiated within 30 minutes of chest wall closure.
All CMR scans were performed on a 1.5 Tesla system with
a 12-element phased-array cardiac coil (MAGNETOM
Avanto, Siemens Medical Solutions, Inc.; Erlangen, Germany).
Identical imaging protocols were used in both groups of
animals, NSTE-ACS model and sham. In the NSTE-ACS
model dogs, scans were performed immediately after
15 minutes of epicardial pacing at 180-210 beats/min
(60-70% of normal canine maximum heart rate vs. average
stable post-anesthesia heart rate of 100 beats/min).
We acquired multiplane cines to measure LV systolic
function, T2 maps to identify areas of acute injury,
first-pass perfusion imaging of microcirculatory myocar-
dial blood flow, and LGE images to visualize areas of
necrosis. Further detailed information is provided in
Additional file 1.
Image analysis
Two investigators analyzed all images by consensus
review (HC and TT). For analysis of T2 maps, myocardial
regions of interest (ROIs) were drawn encompassing the
affected region and remote region for each dog (typically
in the regions of segments 9 and 12 by standardized LV
segmentation nomenclature [11]), and the mean T2 in
each ROI was recorded. Perfusion images were visually
scored by counting the number of LV segments that
showed abnormalities. LGE images were similarly evaluated
using consistent display settings. LV ejection fraction was
calculated using Simpson’s rule and manual segmentation
of the endocardial border on end-systolic and end-diastolic
frames of contiguous short-axis cines.
Coronary blood flow determination via microspheres
To verify the changes in coronary blood flow due to sten-
osis and pacing, we injected fluorescent microspheres
(BioPAL, Inc.; Worcester, MA) into the left atrium of 5
animals (2 NSTE-ACS model and 3 sham) at three time
points, each with a different fluorescent label: 1) prior
to surgical stenosis of the LCx (gold), after stenosis and
pacing (samarium), and just prior to euthanasia (lutetium).
The disintegrations per minute (dpm) of each label was
quantified (BioPAL, Inc.) in tissue sections (~1 gram)
obtained from both the affected and remote regions. After
calibration, the dpm of each label was converted to flow
in the affected region relative to the flow in the remote
region at each of the three time points.
Myocardial tissue necrosis and edema determination
Examinations were made on myocardial tissue sections
from both the affected and remote regions in all animals
to determine the presence of tissue necrosis and edema
using established 2,3,5-triphenyltetrazolium chloride (TTC)staining and wet/dry weight ratio measurement, respect-
ively, as described further in Additional file 1.
Light and electron microscopy
Tissue sections harvested from the remote and affected
myocardial regions were routinely processed and stained
[12] (further detailed in Additional file 1). Tissue hist-
ology was graded blindly for evidence of structural and/
or cellular injury/abnormalities by pathologist (PBB) re-
view. High-resolution electron microscopy digital image
analysis of myocardial mitochondrial ultrastructure was
performed [13], and values obtained for the affected
myocardial mitochondria were normalized to those aver-
aged from the corresponding remote myocardial mito-
chondria for the sake of comparison between the groups.
Ex vivo myocardial tissue respiration
To evaluate the effect of ischemia upon cellular respiration
in our NSTE-ACS model, O2 consumption by myocardial
tissue (~0.2-0.3 grams) obtained from both the affected
and remote regions was measured in all animals em-
ploying standard techniques as further described in
Additional file 1. The rate of mitochondrial respiration
in the affected region was normalized to that of the re-
mote region in each animal and compared between the
model and sham groups.
Myocardial gene expression
Frozen harvested tissue samples from both the affected
and remote myocardial regions obtained from each animal
were processed according to standard techniques to isolate
high quality total RNA, as detailed in Additional file 1.
Gene expression for select canine genes in both the
affected and remote myocardial regions was determined
using quantitative real-time PCR. Relative copy numbers
and expression ratios for all genes of interest were normal-
ized to that of the housekeeping gene, β-actin, and then
compared within the model group.
Statistical analysis
Results are reported as mean ± standard deviation (SD). In
vivo and ex vivo measurements for affected myocardial
tissue respiration in model vs. sham groups were compared
by use of unpaired t-tests. Delta T2 (affected minus
remote) was also compared between the two groups
using unpaired t-tests. For serial microsphere and TnI
data, a two-way analysis of variance (ANOVA) test was
performed to examine the individual contributions of
animal group and sampling time, as well as their interaction
effects. The T2 data was also analyzed in this way using
animal group and region (remote and affected) as the main
effects. Comparisons of selective gene expression between
the affected and remote regions within the model group
Figure 2 Troponin I and ECG. A) Blood was drawn for troponin-I
(TnI) measurement at three time points: baseline/pre-surgery
(Time 0), post-stenosis and post-pacing in model dogs or at the end
of CMR examination in sham dogs (Time 1, approximately 2 hours
after surgery), and just before euthanasia (Time 2, approximately 3
hours after surgery). While thoracotomy and instrumentation
produced minimal TnI elevation in operated sham animals, TnI was
significantly higher (though only mildly elevated) in the NSTE-ACS
model. B) Representative ECG tracings at baseline and after ischemia
(stenosis and pacing) demonstrated premature ventricular contractions
but no ST elevation with ischemic conditions in the NSTE-ACS model.
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significance was based upon a value of p < 0.05.
Results
Of the seven dogs in the NSTE-ACS model group, five
survived the entire experiment. Two expired due to
ventricular fibrillation – one during the initial surgery
and the other during pacing. No pre-euthanasia deaths
occurred in the sham group. No coronary artery anomalies
were identified with the left circumflex artery observed to
supply the lateral LV wall in all operated animals. TnI was
undetectable on serial measurement in the serum of
the 2 unoperated control animals, while thoracotomy
and cardiac instrumentation presumably produced the
borderline TnI elevation (0.44 ± 0.48 ng/mL at final meas-
urement) in operated sham animals. The NSTE-ACS
model resulted in final TnI levels of 1.97 ± 0.72 ng/mL,
which was significantly higher than the operated sham
animals (p = 0.02) and the averaged final TnI levels across
all sham animals (0.27 ± 0.41 ng/mL, p < 0.01) (Figure 2A);
no significant ST segment elevation was observed in
the NSTE-ACS model animals throughout any of the
experiments (Figure 2B). Two-way ANOVA showed
significant contributions to TnI changes due to time
(p < 0.001), animal group (p < 0.001), and time-group
interaction (p < 0.001).
In vivo imaging
LV ejection fraction by CMR acquired during anesthesia
was mildly reduced in the model dogs with LCx stenosis
post-pacing compared to the sham dogs (40 ± 2 vs.
48 ± 8%, p = 0.03). Myocardial T2 was increased in the
LCx-territory myocardium relative to remote myocardium
in NSTE-ACS model dogs after pacing (Figure 3), aver-
aging 53.2 ± 4.9 ms in the affected region vs. 43.6 ± 2.8
ms in the remote region. A smaller regional difference
in myocardial T2 was also present in sham animals
(48.6 ± 2.1 vs. 43.4 ± 2.9 ms; Figure 4), somewhat larger
in those that were unoperated (46.3 ± 1.6 vs. 40.0 ± 0.6
ms) vs. operated (49.7 ± 1.1 vs. 45.2 ± 1.4 ms). Two-way
ANOVA showed significant contributions to T2 due to
myocardial region (p < 0.001), animal group (p = 0.02),
and region-group interaction (p = 0.03). Perfusion and
LGE images showed no first-pass defect, microvascular
obstruction or enhancement (Figure 3) in any model or
sham-operated animals.
Myocardial blood flow and tissue oxygen metabolism
An average of 38,395 microspheres was collected for
each reading. In the NSTE-ACS model dogs, the flow
through the affected region relative to the flow through
the remote region decreased after stenosis and pacing
with a mean end-experiment flow ratio of 0.53 ± 0.36.
Lack of stenosis and pacing in the sham dogs resultedin no change in myocardial blood flow over the course of
the experiment where end-experiment flow ratio averaged
1.0 ± 0.10 (Figure 5A). Two-way ANOVA showed sig-
nificant contributions to this flow ratio due to time
(p < 0.001), animal group (p < 0.001), and time-group
interaction (p < 0.001). In six sham animals, the myocar-
dial respiration rate from the affected and remote regions
was 0.44 ± 0.10 nmol O2/mg/min and 0.43 ± 0.08 nmol
O2/mg/min, respectively, yielding an average respiration
rate ratio of 1.04 ± 0.07. In four NSTE-ACS model dogs,
the myocardial respiration rate from the affected and
remote regions was 0.44 ± 0.07 nmol O2/mg/min and
0.61 ± 0.05 nmol O2/mg/min, respectively, resulting in
a significantly lower respiration rate ratio of 0.72 ± 0.07
when compared to the sham group (p < 0.001, Figure 5B).
These findings are in keeping with previous investigations
wherein tissue hypoxia was shown to limit pacing-induced
aerobic respiration [14], indicating that the affected
Figure 3 Myocardium at risk without necrosis. T2 maps and late
gadolinium enhancement (LGE) images are shown in a mid
short-axis plane from representative sham and NSTE-ACS model
animals. In the sham, mild T2 elevation was observed in the affected
area (solid arrow) compared to the remote region (dotted arrow). In
the model, creation of left circumflex coronary artery stenosis and
tachycardic pacing produced significantly more pronounced
myocardial T2 elevation in the affected area. LGE demonstrated no
myocardial enhancement.
Figure 4 T2 Values. T2 values from remote and affected
myocardial regions are shown for the sham and the NSTE-ACS
model groups. The T2 difference (affected – remote) was
significantly larger in the model group than in the sham group
(9.6 ± 4.2 ms vs. 5.1 ± 1.2 ms, p = 0.02). Asterisks indicate outlier
values from one sham dog.
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or near its maximal aerobic capacity at baseline.
Tissue pathology
Immediate post-mortem analysis of fresh tissue revealed
comparable wet-to-dry ratios in the affected region in
the NSTE-ACS dogs compared to the matching remote
regions or compared to matching myocardial tissues
from sham animals. In addition, the results demon-
strated no change in wet-to-dry ratios related to the sur-
gical preparation (Additional file 1: Table S3). Staining of
fresh tissues obtained from the affected and remote
myocardial regions with TTC was negative indicating an
absence of non-viable myocardium in tissue samples
(2-3 mm slice thickness) corresponding to the abnormal
T2 signal by this technique (Additional file 1: Figure S1).
In keeping with the TTC findings and negative LGE
results on CMR, light microscopy generally showed no
increase in contraction band necrosis, a marker of irre-
versible cellular injury, in the affected region. Small
areas with contraction band-like patterns were seen in
both sham and model groups, suggesting an artifact of
the tissue cutting and preparation process or transient
myocardial fasciculations in the immediate post-mortem
period. Unexpectedly, mitochondrial size was statistically
greater in the myocardium of the lateral wall compared
to the anterior wall in all animals, but normalized data
indicated no mitochondrial swelling relative to controls
or other manifestations of mitochondrial damage in the
NSTE-ACS dogs (Figure 6).
CaMKIID and mitochondrial gene expression during
NSTE-ACS
Enhanced expression of CaMKIID, a pleiotropic kinase
that is responsive to changes in intracellular calcium [15],
was observed within 3 hours in the affected myocardium
in the NSTE-ACS model (Figure 7A). There was no
significant change in HIF-1α gene expression in the
affected myocardium (Figure 7B). In keeping with pre-
vious studies showing that myocardial mitochondrial
biogenesis is promoted in response to ischemia [16], T2
changes within the affected myocardium of the NSTE-
ACS animals correlated with increased mitochondria-
related gene expression (Figure 7C).
Discussion
There are two important and novel findings of the
present study: 1) a canine model based upon reduced
myocardial oxygen supply (coronary stenosis) and increased
myocardial oxygen demand (tachycardic pacing) mimics
key features of clinical NSTE-ACS and 2) increased myo-
cardial T2 conforms to an early form of myocardial damage
that is associated with viable myocardium, as indicated
by the absence of late gadolinium enhancement on CMR
Figure 5 Myocardial blood flow and respiration. A) The change in myocardial blood flow through the affected region (relative to the flow
through the remote region at that point in time) is shown at three time points: baseline (Time 0), post-stenosis and post-pacing or at the end of
imaging in sham animals (Time 1), and just before euthanasia (Time 2), with a significant decrease in blood flow with the model. B) Ex vivo
myocardial respiration rates in the affected region normalized to rates in the remote region were significantly lower in the NSTE-ACS model vs.
that in sham animals.
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in vivo imaging findings corresponded to a reduction in
tissue respiration without signs of irreversible cell or
mitochondrial injury by ex vivo analyses. Together, this
is in keeping with an adaptive state such as myocardial
stunning that defines myocardium at risk for subse-
quent irreversible injury and adverse remodeling [17].
Indeed, the observed decline in myocardial blood flow
by microsphere analysis and increase in myocardial
injury by TnI just prior to euthanasia suggests that theearlier identification of myocardium with increased T2
but no LGE identifies at-risk but potentially salvageable
myocardium.
NSTE-ACS encompasses a wide range of pathophysi-
ologies, but a clear distinction from STEMI is its relative
lack of complete/sustained coronary artery occlusion [18].
Without complete thrombotic occlusion, patients pre-
senting with NSTE-ACS typically lack the obvious ST
elevation by ECG and the more dramatic symptoms of
patients with STEMI. As a result, they are not treated with
Figure 6 (See legend on next page.)
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Figure 6 Microscopy. Top) Representative light photomicrographs from animals in the sham (A) vs. NSTE-ACS model (B) groups. H&E staining
revealed no significant contraction band necrosis to indicate irreversible cell death in either group. Middle) Representative electron photomicrographs
of left ventricular myocardial tissue (noting the mitochondria – arrows) corresponding to the remote region from a representative sham animal
(C, white), the matching affected region from the same sham animal (D, green), the remote region from a representative animal from the model
group (E, white) and the matching affected region from the same model animal (F, green) (Original magnification: 11,000×; Staining: 2% uranyl
acetate and Reynolds lead citrate). Bottom) Electron microscopy showed no evidence of mitochondrial damage (e.g., decreased matrix density,
disintegration of cristae) or structural signs of irreversible muscle damage. Although mitochondria were noted to be consistently larger in the lateral
LV wall compared to the anterior LV wall in controls and NSTE-ACS model animals, there was no objective evidence of mitochondrial swelling, as
reflected by computer-derived measures of mitochondrial transectional area, perimeter and aspect ratio, in the NSTE-ACS group. Data presented as
ratios of measurements made on mitochondria within the affected region relative to those made on corresponding mitochondria within the remote
region in the same animal.
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ment or hospital yet suffer considerable morbidity and may
have even higher long-term mortality than STEMI patients
[3]. Even an emphasis on early invasive management in
most NSTE-ACS patients continues to carry uncertaintyFigure 7 Gene expression. Quantitative real-time PCR was used to measu
expression (C) in the remote and affected myocardial regions in the NSTE-
significant induction of the expression of CaMKIID and multiple mitochond
complex in the affected region compared to the remote (non-ischemic) reregarding consistent benefit [19]. These clinical realities
underscore the importance of understanding this syndrome
at a more fundamental level in order to identify substrates
for poor outcomes in these patients and to discover targets
to improve evaluation and treatment pathways.re nuclear CaMKIID (A), HIF-1α (B) and mitochondria- related gene
ACS model group. The NSTE-ACS model was associated with
ria-related genes representing components of each cytochrome
gion.
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addressed the need for an adequate animal model to
enable studies corroborating in vivo findings with ex vivo
ultrastructural and functional assays. Using CMR tech-
niques that readily translate to clinical application, we
demonstrated myocardial T2 increase without significant
myocardial necrosis by LGE. This paralleled mild TnI
elevation but without ST elevation, plus ultrastructural
and genetic changes that together corresponded to
altered yet potentially viable myocardium. Our goal was
not to produce a fixed amount of injury but rather to
produce ischemic injury consistently without significant
necrosis. The microsphere data demonstrated that reliable
reductions in blood flow were achieved in the affected
myocardium vs. the remote region in this dog model,
despite the known presence of highly variable coronary
artery collaterals in canines [20].
The translational value of these findings is evident
when considering that the protocol can be readily im-
plemented not only in prospective patient studies but
also in preclinical studies aimed at better understanding
the mechanisms that alter cellular and organ function.
Our demonstration of altered expression of CaMKIID
and associated increases in mitochondrial biogenesis,
consistent with myocardial adaptation to acute ischemia
[15,16], is an important first step in this direction as this
protective pathway can be targeted through pharmacologic
and non-pharmacologic mechanisms [21,22]. As such, CMR
T2 alterations in the context of NSTE-ACS may identify
patients who would benefit from early revascularization or
other more novel approaches.
In finding a smaller but consistently positive difference
between T2 in the lateral vs. anterior LV myocardium in
sham animals, we further demonstrated physiological
heterogeneity in T2 and mitochondrial size that may
reflect previously-described regional variation in myocardial
oxygen consumption [23]. Notably, human studies have
also demonstrated variation in myocardial T2 across LV
segments [24,25]. Given that mitochondria i) represent a
large fraction of total myocardial volume, ii) are fluid
enriched relative to muscle and iii) are much larger in the
lateral wall, we suspect that regional differences in mito-
chondrial size could account for the observed variation
in T2 values in the control group. Nonetheless, the T2
difference was significantly greater in the NSTE-ACS
model vs. that seen in the sham animals.
A common explanation for increased T2 is the presence
of myocardial edema. Other animal studies have found
increased water content in ischemic myocardium correlated
to the degree of stunning [26]. However, many of these
studies involve more STEMI-like models with complete
occlusion or multiple short cycles of brief occlusion
causing cardioprotective post-ischemic conditioning. Our
model, which lacks complete coronary occlusion andmay better mimic human NSTE-ACS, did not produce
a significant difference in wet vs. dry weight of affected
myocardium. Elevated T2 in the absence of net water
influx suggests an increase in the ratio of free-to-bound
water in the affected myocardium as is known to occur as
a consequence of the molecular and cellular responses to
hypoxia, including acidosis [27-30]. However, the precise
mechanisms responsible for myocardial T2 increase in
ischemia remain poorly defined.
One potential mechanism involves mitochondria. Tissue
aerobic respiration in the model group was significantly
lower than in the sham dogs, indicating reduced mito-
chondrial oxygen consumption in the affected myocardium.
Considering that mitochondrial ultrastructure and ADP-
dependent respiratory capacity (data not shown) remained
intact in the affected tissue during NSTE-ACS, the
observed suppression of oxygen consumption likely reflects
the shift from aerobic to glycolytic ATP production that
characterizes myocardial stunning in the context of
ischemia, which is regulated by HIF-1α and CaMKII in
response to changes in tissue oxygen [31] and calcium
[32], respectively. The observed change in CaMKIID
expression and lack of HIF-1α response suggests that
changes in intracellular calcium flux may contribute to
the observed metabolic adaptations in the ischemic tissue.
Moreover, high-level evidence indicates that sustained
CaMKII activation can lead to myocardial remodeling
and dysfunction [33]. Further investigation will be required
to understand to what extent the cell is responding
mal-adaptively or adaptively to ischemia and to delineate
the time course for irreversible adaptive changes.
At the same time, we also demonstrated that significant
ischemic cell death does not appear to be present in
this model of NSTE-ACS. A large body of literature has
documented that mitochondrial swelling is the earliest
sign of impending necrotic cell death, and widespread
high-amplitude mitochondrial degeneration portends
irreversible ischemic injury [34,35]. In the present study,
we specifically looked for the earliest signs of mito-
chondrial damage under electron microscopy along with
contraction band necrosis by H&E staining. While EM
studies were conclusively negative for necrosis and did
not indicate mitochondrial damage, some H&E sections
in both sham and model animals did show contraction
band-like patterns. The interpretation of these patterns
as an artifact of tissue preparation is further supported
by the absence of enhancement on pre-mortem LGE
images of the affected region and lack of abnormality
on post-mortem TTC staining.
Limitations
Despite the advantages of this large-animal model (e.g.,
compared to rodents [36]) in terms of modeling human
ischemic heart disease, we recognize certain model
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mia beyond a 3-4 hour window; as such, the conse-
quence of the observed T2 alterations in terms of
longer-term tissue viability remains unclear. Due to con-
cerns regarding adequate myocardial tissue availability
after histopathological and oxygen respiration analyses,
and the lack of invasive catheterization in unoperated
shams, microspheres were only delivered in 5 animals.
While we did not directly measure coronary artery sten-
osis or absolute coronary blood flow rates (only relative
flow rates were obtained), this model produces mechanical
restriction of the cross sectional coronary diameter (as
dictated by the surgical protocol) and was shown to reli-
ably reduce tissue perfusion, particularly following de-
mand pacing, as reflected by tissue microsphere
quantification. Absolute flow measurements may be in-
corporated into future studies. In terms of tissue bio-
energetics, while it would be optimal to measure
in vivo myocardial VO2 and ATP levels, the demon-
strated decrease in tissue VO2 measured ex vivo under
conditions of excess oxygen supply and associated
changes in CaMKIID and mitochondrial biogenesis are
in keeping with established bioenergetics adaptations to
tissue hypoxia [15,37]. It is postulated that a lower meta-
bolic state (stunning or hibernation) and a transition from
aerobic towards anaerobic respiration is an adaptation that
prevents lethal ATP depletion in the context of limited
oxygen supply; further investigation using techniques such
as phosphorus spectroscopy would help corroborate or
refute this proposition.
Conclusions
In a large animal model based on demand myocardial
ischemia seen in the predominant form of NSTE-ACS
in humans, myocardial T2 increases with corresponding,
presumably adaptive, reduction in myocardial tissue re-
spiratory function and preserved ultra structural findings
indicating myocardial viability. The observed changes in
oxygen metabolism and mitochondrial biogenesis, hallmarks
of myocardial hibernation, suggest that antecedent T2
elevation without LGE identifies myocardium at risk of
subsequent irreversible injury. Additional studies using
this model to examine long-term changes and the impact
of therapeutic maneuvers to restore normal T2 and
mitochondrial function may further elucidate the syn-
drome of NSTE-ACS and guide management changes
to improve outcomes.
Additional file
Additional file 1: Additional methods and results for CMR and
tissue assays. Figure S1. Representative left ventricular myocardial
tissue slices, post-TTC staining, demonstrate no evidence of necrosis.
For each one, both sides of the slice are shown (left-right). The topthree pairs (A-B, C-D, E-F) correspond to the affected regions
(demonstrating the elevated T2 signal anatomically associated to the
area with the papillary muscle, arrow) in 3 animals from the NSTE-ACS
model group. Pair G-H corresponds to the affected region in a
representative sham animal. Pair I-J corresponds to the remote region
in a representative animal from the NSTE-ACS model group (the same
one presented in pair A-B). Evidence of necrosis is absent in all slices,
particularly within the affected regions. Table S1. CMR Scan
Parameters. Table S2. Canine Primer Sequences Used for Real-time
PCR. Table S3. Tissue Percent Water Content in the Myocardial
Affected Region Alone and Normalized to That in the Corresponding
Myocardial Remote Region.
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